Survey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014–2020

Abstract Background Pretreatment drug resistance (PDR) can limit the effectiveness of HIV antiretroviral therapy (ART). The aim of this study was to assess the prevalence of PDR among HIV-positive individuals that initiated antiretroviral therapy in 2014–2020 in southwestern China. Methods Consecuti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaoshan Xu, Liuhong Luo, Chang Song, Jianjun Li, Huanhuan Chen, Qiuying Zhu, Guanghua Lan, Shujia Liang, Zhiyong Shen, Zhiqiang Cao, Yi Feng, Lingjie Liao, Hui Xing, Yiming Shao, Yuhua Ruan
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
HIV
Acceso en línea:https://doaj.org/article/f3ceeb595f7345d3b0e70ccb0bc98457
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f3ceeb595f7345d3b0e70ccb0bc98457
record_format dspace
spelling oai:doaj.org-article:f3ceeb595f7345d3b0e70ccb0bc984572021-11-14T12:44:19ZSurvey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014–202010.1186/s12879-021-06847-51471-2334https://doaj.org/article/f3ceeb595f7345d3b0e70ccb0bc984572021-11-01T00:00:00Zhttps://doi.org/10.1186/s12879-021-06847-5https://doaj.org/toc/1471-2334Abstract Background Pretreatment drug resistance (PDR) can limit the effectiveness of HIV antiretroviral therapy (ART). The aim of this study was to assess the prevalence of PDR among HIV-positive individuals that initiated antiretroviral therapy in 2014–2020 in southwestern China. Methods Consecutive cross-sectional surveys were conducted in Qinzhou, Guangxi. We obtained blood samples from individuals who were newly diagnosed with HIV in 2014–2020. PDR and genetic networks analyses were performed by HIV-1 pol sequences using the Stanford HIV-database algorithm and HIV-TRACE, respectively. Univariate and multivariate logistic regression models were used to explore the potential factors associated with PDR. Results In total, 3236 eligible HIV-positive individuals were included. The overall prevalence of PDR was 6.0% (194/3236). The PDR frequency to NNRTI (3.3%) was much higher than that of NRTI (1.7%, p < 0.001) and PI (1.2%, p < 0.001). A multivariate logistic regression analysis revealed that PDR was significantly higher among individuals aged 18–29 (adjusted odds ratio (aOR): 1.79, 95% CI 1.28–2.50) or 30–49 (aOR: 2.82, 95% CI 1.73–4.82), and harboring CRF08_BC (aOR: 3.23, 95% CI 1.58–6.59). A total of 1429 (43.8%) sequences were linked forming transmission clusters ranging in size from 2 to 119 individuals. Twenty-two individuals in 10 clusters had the same drug resistant mutations (DRMs), mostly to NNRTIs (50%, 5/10). Conclusions The overall prevalence of PDR was medium, numerous cases of the same DRMs among genetically linked individuals in networks further illustrated the importance of surveillance studies for mitigating PDR.Xiaoshan XuLiuhong LuoChang SongJianjun LiHuanhuan ChenQiuying ZhuGuanghua LanShujia LiangZhiyong ShenZhiqiang CaoYi FengLingjie LiaoHui XingYiming ShaoYuhua RuanBMCarticleHIVPretreatment drug resistance (PDR)Antiretroviral therapy (ART)Drug resistance mutations (DRMs)Genetic transmission networksInfectious and parasitic diseasesRC109-216ENBMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic HIV
Pretreatment drug resistance (PDR)
Antiretroviral therapy (ART)
Drug resistance mutations (DRMs)
Genetic transmission networks
Infectious and parasitic diseases
RC109-216
spellingShingle HIV
Pretreatment drug resistance (PDR)
Antiretroviral therapy (ART)
Drug resistance mutations (DRMs)
Genetic transmission networks
Infectious and parasitic diseases
RC109-216
Xiaoshan Xu
Liuhong Luo
Chang Song
Jianjun Li
Huanhuan Chen
Qiuying Zhu
Guanghua Lan
Shujia Liang
Zhiyong Shen
Zhiqiang Cao
Yi Feng
Lingjie Liao
Hui Xing
Yiming Shao
Yuhua Ruan
Survey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014–2020
description Abstract Background Pretreatment drug resistance (PDR) can limit the effectiveness of HIV antiretroviral therapy (ART). The aim of this study was to assess the prevalence of PDR among HIV-positive individuals that initiated antiretroviral therapy in 2014–2020 in southwestern China. Methods Consecutive cross-sectional surveys were conducted in Qinzhou, Guangxi. We obtained blood samples from individuals who were newly diagnosed with HIV in 2014–2020. PDR and genetic networks analyses were performed by HIV-1 pol sequences using the Stanford HIV-database algorithm and HIV-TRACE, respectively. Univariate and multivariate logistic regression models were used to explore the potential factors associated with PDR. Results In total, 3236 eligible HIV-positive individuals were included. The overall prevalence of PDR was 6.0% (194/3236). The PDR frequency to NNRTI (3.3%) was much higher than that of NRTI (1.7%, p < 0.001) and PI (1.2%, p < 0.001). A multivariate logistic regression analysis revealed that PDR was significantly higher among individuals aged 18–29 (adjusted odds ratio (aOR): 1.79, 95% CI 1.28–2.50) or 30–49 (aOR: 2.82, 95% CI 1.73–4.82), and harboring CRF08_BC (aOR: 3.23, 95% CI 1.58–6.59). A total of 1429 (43.8%) sequences were linked forming transmission clusters ranging in size from 2 to 119 individuals. Twenty-two individuals in 10 clusters had the same drug resistant mutations (DRMs), mostly to NNRTIs (50%, 5/10). Conclusions The overall prevalence of PDR was medium, numerous cases of the same DRMs among genetically linked individuals in networks further illustrated the importance of surveillance studies for mitigating PDR.
format article
author Xiaoshan Xu
Liuhong Luo
Chang Song
Jianjun Li
Huanhuan Chen
Qiuying Zhu
Guanghua Lan
Shujia Liang
Zhiyong Shen
Zhiqiang Cao
Yi Feng
Lingjie Liao
Hui Xing
Yiming Shao
Yuhua Ruan
author_facet Xiaoshan Xu
Liuhong Luo
Chang Song
Jianjun Li
Huanhuan Chen
Qiuying Zhu
Guanghua Lan
Shujia Liang
Zhiyong Shen
Zhiqiang Cao
Yi Feng
Lingjie Liao
Hui Xing
Yiming Shao
Yuhua Ruan
author_sort Xiaoshan Xu
title Survey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014–2020
title_short Survey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014–2020
title_full Survey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014–2020
title_fullStr Survey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014–2020
title_full_unstemmed Survey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014–2020
title_sort survey of pretreatment hiv drug resistance and the genetic transmission networks among hiv-positive individuals in southwestern china, 2014–2020
publisher BMC
publishDate 2021
url https://doaj.org/article/f3ceeb595f7345d3b0e70ccb0bc98457
work_keys_str_mv AT xiaoshanxu surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT liuhongluo surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT changsong surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT jianjunli surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT huanhuanchen surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT qiuyingzhu surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT guanghualan surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT shujialiang surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT zhiyongshen surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT zhiqiangcao surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT yifeng surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT lingjieliao surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT huixing surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT yimingshao surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
AT yuhuaruan surveyofpretreatmenthivdrugresistanceandthegenetictransmissionnetworksamonghivpositiveindividualsinsouthwesternchina20142020
_version_ 1718429083305508864